Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Mattin MJ, Boswood A, Church DB, et al. Prevalence of and risk factors for degenerative mitral valve disease in dogs attending primary-care veterinary practices in England. J Vet Intern Med. 2015;29(3):847–854. doi:10.1111/jvim.12591
-
2.
Häggström J, Boswood A, O’Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124–1135. doi:10.1111/j.1939–1676.2008.0150.x
-
3.
de Madron E, King JN, Strehlau G, Valle White R. Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases. Can Vet J. 2011;52(11):1219–1225.
-
4.
Beaumier A, Rush JE, Yang VK, Freeman LM. Clinical findings and survival time in dogs with advanced heart failure. J Vet Intern Med. 2018;32(3):944–950. doi:10.1111/jvim.15126
-
5.
Mizuno M, Yamano S, Chimura S, et al. Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure. J Vet Med Sci. 2017;79(1):29–34. doi:10.1292/jvms.16-0069
-
6.
Markby GR, Summers KM, MacRae VE, Corcoran BM. Comparative transcriptomic profiling and gene expression for myxomatous mitral valve disease in the dog and human. Vet Sci. 2017;4(3):34 doi:10.3390/vetsci4030034
-
7.
Ling H, Enriquez-Sarano M, Seward J, et al. Clinical outcome of mitral regurgitation due to flail leaflets. N Eng J Med. 1996;335(19):1417–1423. doi:10.1056/NEJM199611073351902
-
8.
Seeburger J, Katus H, Pleger ST, Krumsdorf U, Mohr F-W, Bekeredjian R. Percutaneous and surgical treatment of mitral valve regurgitation. Dtsch Arztebl Int. 2011;108(48):816–821. doi:10.3238/arztebl.2011.0816
-
9.
De Bonis M, Al-Attar N, Antunes M, et al. Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. Eur Heart J. 2016;37(2):133–139. doi:10.1093/eurheartj/ehv322
-
10.
Uechi M, Mizukoshi T, Mizuno T, et al. Mitral valve repair under cardiopulmonary bypass in small breed dogs: 48 cases (2006–2009). J Am Vet Med Assoc. 2012;240(10):1194–1201. doi:10.2460/javma.240.10.1194
-
11.
Bristow P, Tsumugi A. Repair of the myxomatous mitral valve: case selection and surgical technique. In: 2021 ACVIM Virtual Scientific Sessions Forum.
-
12.
Keene BW, Atkins CE, Bonagura JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33(3):1127–1140. doi:10.1111/jvim.15488
-
13.
Griffiths LG, Orton EC, Boon JA. Evaluation of techniques and outcomes of mitral valve repair in dogs. J Am Vet Med Assoc. 2004;224(12):1941–1945. doi:10.2460/javma.2004.224.1941
-
14.
Mizuno T, Mizukoshi T, Uechi M. Long-term outcome in dogs undergoing mitral valve repair with suture annuloplasty and chordae tendinae replacement. J Small Anim Pract. 2013;54:104–107. doi:10.1111/j.1748-5827.2012.01305.x
-
15.
Mellanby RJ, Herrtage ME, Dobson JM. Owners’ assessments of their dog’s quality of life during palliative chemotherapy for lymphoma. J Small Anim Pract. 2003;44:100–103. doi:10.1111/j.1748-5827.2003.tb00127.x
-
16.
Wiseman-Orr ML, Scott EM, Reid J, Nolan AM. Validation of a structured questionnaire as an instrument to measure chronic pain in dogs on the basis of effects on health-related quality of life. Am J Vet Res. 2006;67(11):1826–1836. doi:10.2460/ajvr.67.11.1826
-
17.
Budke CM, Levine JM, Kerwin SC, et al. Evaluation of a questionnaire for obtaining owner-perceived, weighted quality-of-life assessments for dogs with spinal cord injuries. J Am Vet Med Assoc. 2008;233(6):925–930. doi:org/10.2460/javma.233.6.925
-
18.
Favrot C, Linek M, Mueller R, et al. Development of a questionnaire to assess the impact of atopic dermatitis on health-related quality of life of affected dogs and their owners. Vet Dermatol. 2010;21:64–70. doi:10.1111/j.1365-3164.2009.00781.x
-
19.
Niessen SJ, Powney S, Guitian J, et al. Evaluation of a quality-of-life tool for cats with diabetes mellitus. J Vet Intern Med. 2010;24:1098–1105. doi:10.1111/j.1939-1676.2010.0579.x
-
20.
German AJ, Holden SL, Wiseman-Orr ML, et al. Quality of life is reduced in obese dogs but improves after successful weight loss. Vet J. 2012;192:428–443. doi:10.1016/j.tvjl.2011.09.015
-
21.
Niessen SJ, Powney S, Guitian J, et al. Evaluation of a quality-of-life tool for dogs with diabetes mellitus. J Vet Intern Med. 2012;26:953–961. doi:10.1111/j.1939-1676.2012.00947.x
-
22.
Iliopoulou MA, Kitchell BE, Yuzbasiyan-Gurkan V. Development of a survey instrument to assess health-related quality of life in small animal cancer patients treated with chemotherapy. J Am Vet Med Assoc. 2013;242(12):1679–1687. doi:10.2460/javma.242.12.1679
-
23.
Bristow P, Lipscomb V, Kummeling A, et al. Health-related quality of life following surgical attenuation of congenital portosystemic shunts versus healthy controls. J Small Anim Pract. 2019;60(1):21–26. doi:10.1111/jsap.12927
-
24.
Schofield I, O’Neill DG, Brodbelt DC, et al. Development and evaluation of a health-related quality-of-life tool for dogs with Cushing’s syndrome. J Vet Intern Med. 2019;33:2595–2604. doi:10.1111/jvim.15639
-
25.
Freeman LM, Rush JE, Farabaugh AE, et al. Development and evaluation of a questionnaire for assessing health-related quality of life in dogs with cardiac disease. J Am Vet Med Assoc. 2005;226(11):1864–1868. doi:10.2460/javma.2005.226.1864
-
26.
Horner-Johnson W, Krahn G, Andresen E, et al. Developing summary scores of health-related quality of life for a population-based survey. Public Health Rep. 2009;124(1):103–110. doi:10.1177/003335490912400113
-
27.
Westlake C, Dracup K, Creaser J. Correlates of health-related quality of life in patients with heart failure. Heart Lung. 2002;31(2):85–93. doi:10.1067/MHL.2002.122839
-
28.
Chen H, Taichman D, Doyle R. Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension. Proc Am Thorac Soc. 2008;5(5):623–630. doi:10.1513/pats.200802-020SK
-
29.
The IMPROVE Study Group. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. J Vet Intern Med. 1995;9(4):234–242. doi:10.1111/j.1939-1676.1995.tb01074.x
-
30.
Smith PJ, French AT, Van Israël N, et al. Efficacy and safety of pimobendan in canine heart failure caused by myxomatous mitral valve disease. J Small Anim Pract. 2005;46(3):121–130. doi:10.1111/jvim.14586
-
31.
Lewis EF, Johnson PA, Johnson W, et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20(9):1016–1024. doi:10.1016/s1053-2498(01)00298-4
-
32.
Juenger J, Schellberg D, Kraemer S, et al. Health-related quality of life in patients with congestive heart failure: Comparison with other chronic diseases and relation to functional variables. Heart. 2002;87(3):235–241. doi:10.1136/heart.87.3.235
-
33.
Riedinger MS, Dracup KA, Brecht ML. Quality of life in women with heart failure, normative groups, and patients with other chronic conditions. Am J Crit Care. 2002;11(3):211–219. doi:10.1016/j.hrtlng.2008.04.002
-
34.
Oyama MA, Rush JE, O’Sullivan ML, et al. Perceptions and priorities of owners of dogs with heart disease regarding quality versus quantity of life for their pets. J Am Vet Med Assoc. 2008;233(1):104–108. doi:10.2460/javma.233.1.104
-
35.
Reynolds CA, Oyama MA, Rush JE, et al. Perceptions of quality of life and priorities of owners of cats with heart disease. J Vet Intern Med. 2010;24(6):1421–1426. doi:10.1111/j.1939–1676.2010.0583.x
-
36.
Williams C, Miller-Sonet E, Nipp R, et al. Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians. Cancer. 2020;126(15):3534–3541. doi:10.1002/cncr.32961
-
37.
International Small Animal Cardiac Health Council. Appendix 1: recommendations for the diagnosis of heart disease and treatment of heart failure in small animals. In: Tilley LP, Goodwin JK, eds. Manual of Canine and Feline Cardiology. 3rd ed. WB Saunders Co; 2001:459–489.
-
38.
Ferasin L, Crews L, Biller DS, et al. Risk factors for coughing in dogs with naturally acquired myxomatous mitral valve disease. J Vet Intern Med. 2013;27(2):286–292. doi:10.1111/jvim.12039
-
39.
Singh MK, Johnson LR, Kittleson MD, et al. Bronchomalacia in dogs with myxomatous mitral valve degeneration. J Vet Intern Med. 2012;26(2):312–319. doi:10.1111/j.1939–1676.2012.00887.x
-
40.
Madaric J, Watripont P, Bartunek J, et al. Effect of mitral valve repair on exercise tolerance in asymptomatic patients with organic mitral regurgitation. Am Heart J. 2007;154(1):180–185. doi:10.1016/j.ahj.2007.03.051
-
41.
Liu NC, Sargan DR, Adams VJ, Ladlow JF. Characterisation of brachycephalic obstructive airway syndrome in French Bulldogs using whole-body barometric plethysmography. PLoS One. 2015;10(6):e0130741. doi:10.1371/journal.pone.0130741
-
42.
Ericksen V, Westlake C, Dracup K, et al. Sleep disturbance symptoms in patients with heart failure. AACN Adv Crit Care. 2003;14(4):477–487. doi:10.1097/00044067-200311000-00009
-
43.
Randerath W, Deleanu O, Schiza S, Pepin J-L. Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options. Eur Respir Rev. 2019;28:190084. doi:10.1183/16000617.0084-2019
-
44.
Köhnlein T, Welte T, Tan LB, Elliott MW. Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax. 2002;57(6):547–554. doi:10.1136/thorax.57.6.547
-
45.
Whooley M. Depression and cardiovascular disease: healing the broken-hearted. J Am Med Assoc. 2006;295:2874–2881. doi:10.1001/jama.295.24.2874
-
46.
Gottlieb SS, Khatta M, Friedmann E, et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol. 2004;43(9):1542–1549. doi:10.1016/j.jacc.2003.10.064
-
47.
Dekker RL, Peden AR, Lennie TA, Schooler MP, Moser DK. Living with depressive symptoms: patients with heart failure. Am J Crit Care. 2009;18(4):310–318. doi:10.4037/ajcc2009672
-
48.
Zhao L, Kolm P, Borger MA, et al. Comparison of recovery after mitral valve repair and replacement. J Thorac Cardiovasc Surg. 2007;133(5):1257–1263. doi:10.1016/j.jtcvs.2006.12.048
Advertisement
Use of the Functional Evaluation of Cardiac Health questionnaire to assess health-related quality of life before and after mitral valve repair in dogs with myxomatous mitral valve disease
Abstract
OBJECTIVE
To determine changes in health-related quality of life up to 12 months after surgery in dogs with myxomatous mitral valve disease that undergo mitral valve repair.
ANIMALS
54 dogs that underwent mitral valve repair at a United Kingdom referral hospital.
PROCEDURES
Health-related quality of life was assessed with a previously validated, owner-completed questionnaire before and 1, 3, 6, and 12 months after surgery.
Results
There was a significant decrease in total score (corresponding to reduced negative impact of cardiac disease on quality of life) between the preoperative timepoint and all postoperative timepoints. A significant decrease in total score was also demonstrated between the 1- and 3-month timepoints, but no additional significant changes in total score between adjacent timepoints were identified beyond 3 months after surgery. Significant improvements in individual question scores were found up to 12 months after surgery.
CLINICAL RELEVANCE
Health-related quality of life was significantly improved following mitral valve repair in dogs with myxomatous mitral valve disease and this improvement persisted for up to a year after surgery. These results may be useful when counseling owners of dogs considered candidates for this procedure.
Contributor Notes
Powered by PubFactory